Table 2.
Fc Receptor | Genetic Variant | Related Diseases | |||||
---|---|---|---|---|---|---|---|
Polymorphism | Copy Number Variant | ||||||
Promoter Region | Extracellular Domain | Transmembrane Domain | Intracellular Domain | ||||
FcγRIIa | H131R | R131 allele: Bacterial infection (Low affinity to IgG2) |
|||||
FcγRIIb | −120T/A −343G/C −386G/C |
−343G, −386C−120A allele: SLE (High FcγRIIb expression) |
|||||
FcγRIIIa | 48L/R/H V158F |
F131 allele: Cancer (Low affinity to IgG) |
|||||
FcγRIIIb | NA1 NA2 SH |
NA2 allele: CGD (Low affinity to IgG1 and IgG3) |
|||||
FcRn | VNTR1- VNTR5 | NA | |||||
FcεRI | α-subunit | −66T/C −344C/T |
−66T, −344T allele: Allergic diseases (High FcεRI expression) |
||||
β-subunit | −109C/T | I181L V183L |
E237G | −109T allele: Asthma (High FcεRI expression) L181, L183 allele: Atopy, Asthma (Altered signaling pathway leading to cell activation) G237 allele: Allergy diseases (Activating signal induction) |
|||
γ-subunit | −237A/G | −237A allele: AIA (High FcεRI expression) |
|||||
FcαRI | −114C/T +56C/T |
S248G | −114C, +56C allele: IgAN (High FcαRI expression) G248 allele: SLE (Altered signaling pathway leading to cell activation) |
NA: not analyzable.